Clinical Trial Update: A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of ART4215 for advanced or metastatic solid tumors sponsored by Artios Pharma Ltd has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ART4215

Snippet

Sponsor: Artios Pharma Ltd | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED